Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy
Clinical trial NCT00877500 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00877500
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-30
- Primary completion
- 2026-12-31
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.